Forecare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 16-07-2024
- Paid Up Capital ₹ 4.50 M
as on 16-07-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 1.50 Cr
as on 16-07-2024
- Revenue 45.96%
(FY 2018)
- Profit 14.19%
(FY 2018)
- Ebitda 23.84%
(FY 2018)
- Net Worth -113.68%
(FY 2018)
- Total Assets 5.72%
(FY 2018)
About Forecare Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company has closed loans amounting to ₹1.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Srinivasan Visalakshi, Kasilingam, Kalairajan Kalaiyappan, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24232TN2015PTC099076
- Company No.
099076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2015
- Date of AGM
28 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Forecare Pharmaceuticals?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasan Visalakshi  | Additional Director | 03-Jun-2015 | Current |
| Kasilingam | Director | 03-Feb-2015 | Current |
| Kalairajan Kalaiyappan | Additional Director | 03-Jun-2015 | Current |
| Saraswathy Babu | Additional Director | 18-Feb-2015 | Current |
| Raja Shanmuganathan | Additional Director | 03-Jun-2015 | Current |
| Vijayavarman Mani | Additional Director | 18-Feb-2015 | Current |
Financial Performance of Forecare Pharmaceuticals.
Forecare Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 45.96% increase. The company also saw a substantial improvement in profitability, with a 14.19% increase in profit. The company's net worth observed a substantial decline by a decrease of 113.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Forecare Pharmaceuticals?
In 2018, Forecare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Meenakshi Medical Distributors Private LimitedActive 13 years 5 monthsSrinivasan Visalakshi and Kasilingam are mutual person
- Saptagiri Properties Development Private LimitedActive 30 years 1 month
Kalairajan Kalaiyappan is a mutual person
- Ommeena Pharma Distributors Private LimitedActive 6 years 7 months
Raja Shanmuganathan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Mar 2017 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Forecare Pharmaceuticals?
Forecare Pharmaceuticals has a workforce of 12 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Forecare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Forecare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
